Insulin resistance and HCV: will new knowledge modify clinical management?
Negro
Francesco
F
Divisions of Gastroenterology and Hepatology and of Clinical Pathology, University Hospital, 24, rue Micheli-du-Crest, 1211 Geneva 14, Switzerland. Francesco.Negro@hcuge.ch <Francesco.Negro@hcuge.ch>
D000998:Antiviral Agents / Q000627:therapeutic use*; D005234:Fatty Liver / Q000150:complications / Q000503:physiopathology*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D024821:Metabolic Syndrome / Q000150:complications / Q000503:physiopathology*
D000998:Antiviral Agents